The probability of freedom from recurrence 5 years after surgical excision was higher than with a noninvasive approach in patients with nodular basal cell carcinoma, although the analysis did not show ...
George Csank, MD, who practices at Pittsfield, Mass.-based Berkshire Cosmetic and Reconstructive Surgery "excised the wrong lesion" on a patient, according to the report. Moreover, he agreed that by ...
SQZ Biotechnologies (NYSE:SQZ – Get Free Report) and Precision BioSciences (NASDAQ:DTIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast ...